Program News
News and stories about the UNC Lineberger Leukemia Oncology Program
-
Nanotechnology offers lower cost, high accuracy approach to diagnosing leukemias in low resource countries
A newer, less expensive nanotechnology may make it possible to more accurately diagnose children with acute leukemia in lower income countries, according to findings by Thomas Alexander, MD, MPH, and colleagues.
-
Couple unified through cancer, caregiver struggles
When a significant other is diagnosed with cancer, it can be just as hard on the loved one as it is on the patient. However, Stephen and Jackie Alston found themselves experiencing both roles when they were each diagnosed with cancer years apart.
-
Student-athlete raising awareness, funds for other young people with cancer
Emily Grund, a member of the UNC-Chapel Hill diving team, found support from friends, family and UNC Lineberger programs after being diagnosed with acute promyelocytic leukemia, a rare form of cancer.
-
Immunotherapy after high-dose chemotherapy leads to favorable outcomes in acute myeloid leukemia
Josh Zeidner, MD, Jon Serody, MD, and colleagues report clinical trial outcomes that benefited patients with resistant or relapsed acute myeloid leukemia.
-
Early phase study finds combination therapy effective against difficult to treat leukemia and lymphoma
Thomas Alexander, MD, MPH, and colleagues published findings from a study that found pairing venetoclax with low-dose navitoclax and chemotherapy had promising efficacy in patients with difficult to treat leukemia and lymphoma.
-
Engineered safety switch curbs severe side effects of CAR-T immunotherapy
As part of a study led by Matthew Foster, MD, the advance was seen in a patient enrolled in a clinical trial using CAR-T to treat refractory acute B-cell leukemia.
-
The McKays: Making it through cancer as a family
Duane McKay and his daughter, Maddilyn, had cancer at the same time. Both were treated at the N.C. Cancer Hospital and received bone marrow transplants, with support from their small town community throughout their journey.
-
‘BAH-code’ reader senses gene-silencing tag in cells
Greg Wang, PhD, and colleagues have identified an evolutionarily conserved pathway responsible for “closing down” gene activity in the mammalian cell.